Envoplakin anticorps (AA 1275-1325)
Aperçu rapide pour Envoplakin anticorps (AA 1275-1325) (ABIN7449223)
Antigène
Voir toutes Envoplakin (EVPL) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1275-1325
-
Fonction
- Rabbit anti-EVPL Antibody, Affinity Purified
-
Purification
- Affinity Purified
-
Immunogène
- Between AA 1275 and 1325
-
Isotype
- IgG
-
-
-
-
Indications d'application
- 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- Envoplakin (EVPL)
-
Autre désignation
- EVPL
-
Sujet
- Background: Envoplakin is a member of the plakin family of proteins that forms a component of desmosomes and the epidermal cornified envelope. The gene is located in the tylosis oesophageal cancer locus on chromosome 17q25, and its deletion is associated with both familial and sporadic forms of oesophageal squamous cell carcinoma. Patients suffering from the autoimmune mucocutaneous disorder, paraneoplastic pemphigus, develop antibodies against Envoplakin [taken from NCBI Entrez Gene (Gene ID: 2125)].
-
ID gène
- 2125
-
UniProt
- Q92817
Antigène
-